| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
U2AF59 Blocking Peptide for STJ503450 is synthetically produced from the 480-517 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Immunogen Region: |
480-517 |
| Specificity: |
This blocking peptide is recommended for use in combination with U2AF59 antibody, STJ503450 |
| Immunogen: |
Synthetic peptide taken within amino acid region 480-517 on yeast U2AF59 protein. |
| Background | Necessary for the splicing of pre-mRNA. The SF1-U2AF59-U2AF23 complex has a role in the recognition of the branch site (5 NA-UACUAAC-3 ) , the pyrimidine tract and the 3 NA-splice site at the 3 NA-end of introns. |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
